Multi-Centre Trial Comparing Three Artemisinin-Based Combination Treatments on P. Falciparum Malaria

NCT00484900 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1390

Enrollment

INDUSTRY

Sponsor class

Conditions

Plasmodium Falciparum Malaria

Interventions

DRUG: Co-Arinate FDC
DRUG: Coartem

Sponsor

Dafra Pharma